Elevated cytoplasmic levels of YB-1 have been linked to an increased risk of recurrence in nasopharyngeal carcinoma within a small group of patients treated by radio- or chemoradiotherapy. This evidence concerns the gene YBX1 and nasopharyngeal carcinoma.